Nexgel (NXGL) Cost of Revenue (2018 - 2025)

Nexgel's Cost of Revenue history runs 8 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• Quarterly Cost of Revenue rose 0.51% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (up 15.1% YoY) and the FY2025 annual result came in at $6.9 million, up 16.36% from the prior year.
• Cost of Revenue was $2.0 million for Q4 2025 at Nexgel, up from $1.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.0 million in Q4 2025 and bottomed at $309000.0 in Q1 2021.
• A 5-year average of $998100.0 and a median of $934500.0 in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue surged 139.55% — and 2025, when it declined 5.27%.
• Nexgel's Cost of Revenue stood at $430000.0 in 2021, then climbed by 13.49% to $488000.0 in 2022, then surged by 139.55% to $1.2 million in 2023, then soared by 68.26% to $2.0 million in 2024, then grew by 0.51% to $2.0 million in 2025.
• Business Quant data shows NXGL's Cost of Revenue at $2.0 million in Q4 2025, $1.7 million in Q3 2025, and $1.6 million in Q2 2025.